Abstract
Several sessions at the 6th Conference on Retroviruses and Opportunistic Infections described the current state of pharmacology. Sessions were devoted to Zidovudine (AZT), Stavudine (d4T), and intracellular phosphorylation; the interactions between antiretrovirals and opiates; and Delavirdine (DLV) and Adefovir (ADV) interactions. Also addressed were the pharmacokinetics in patients with liver disease; the toxicities associated with Adefovir and Amprenavir (APV); and the uses of Hydroxyurea (HU).
| Original language | English (US) |
|---|---|
| Journal | The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service |
| Volume | 11 |
| Issue number | 2 |
| State | Published - 1999 |
| Externally published | Yes |
Fingerprint
Cite this
Pharmacology : a progress report. / Flexner, Charles Williams.
In: The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service, Vol. 11, No. 2, 1999.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Pharmacology
T2 - a progress report.
AU - Flexner, Charles Williams
PY - 1999
Y1 - 1999
N2 - Several sessions at the 6th Conference on Retroviruses and Opportunistic Infections described the current state of pharmacology. Sessions were devoted to Zidovudine (AZT), Stavudine (d4T), and intracellular phosphorylation; the interactions between antiretrovirals and opiates; and Delavirdine (DLV) and Adefovir (ADV) interactions. Also addressed were the pharmacokinetics in patients with liver disease; the toxicities associated with Adefovir and Amprenavir (APV); and the uses of Hydroxyurea (HU).
AB - Several sessions at the 6th Conference on Retroviruses and Opportunistic Infections described the current state of pharmacology. Sessions were devoted to Zidovudine (AZT), Stavudine (d4T), and intracellular phosphorylation; the interactions between antiretrovirals and opiates; and Delavirdine (DLV) and Adefovir (ADV) interactions. Also addressed were the pharmacokinetics in patients with liver disease; the toxicities associated with Adefovir and Amprenavir (APV); and the uses of Hydroxyurea (HU).
UR - http://www.scopus.com/inward/record.url?scp=0033086041&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033086041&partnerID=8YFLogxK
M3 - Article
C2 - 11366246
AN - SCOPUS:0033086041
VL - 11
JO - The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service
JF - The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service
SN - 1551-8396
IS - 2
ER -